Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (692)	1/27/2005 12:03:51 PM
From: Jibacoa	Respond to of 3722

Thanks for the list. Looking at the weekly charts, these are the ones which are keeping an Uptrend: CRXL SEPR CATG ZGEN MYGN ENCY AMLN AXCA CYPB OSIP CTIC NRGN PGNX APPX OSCI ARQL DSCO These are on a possible "transition" level.<g> NTII bigcharts.marketwatch.com PDLI bigcharts.marketwatch.com LGND bigcharts.marketwatch.com These are the ones with the most "interesting" weekly charts: ZGEN bigcharts.marketwatch.com CYPB bigcharts.marketwatch.com NRGN bigcharts.marketwatch.com RAGL Bernard

To: Biomaven who wrote (692)	1/27/2005 12:49:08 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 3722

Do you think you might be able to increase your stock picking skill by halving that list?

To: Biomaven who wrote (692)	1/27/2005 2:57:22 PM
From: Galirayo	Respond to of 3722

Peter, Here's a tuff customer to please even if it's not on your list. Message 20990571 Ray

To: Biomaven who wrote (692)	1/29/2005 2:59:34 PM
From: Galirayo	Respond to of 3722

Peter, Thanks for posting your list. I have just finished putting them into an easy to use format. Sorry I'm so slow but this market does not exactly have me thrilled. Too many events on the horizon, if you know what I mean. Here's just a minor rundown without the earnings season stuff. Message 20996678 I was told the Fed is a 2 day meeting. Due Wed. This one is doing .. "The Little Train that Could" In the Face of Mkt Conditions. I may study this one. stockcharts.com I'm going thu them as I can. I think the Flu has arrived in our house. Don't want to be next. :( Ray

To: Biomaven who wrote (692)	1/29/2005 5:43:20 PM
From: Tomato	Read Replies (2) \| Respond to of 3722

"Going down the list in order" In order of $$ owned? Regards, Wayne

To: Biomaven who wrote (692)	2/13/2005 6:50:03 PM
From: CapitalistHogg™	Read Replies (1) \| Respond to of 3722

This is nice. Should get a nice pop on ENCY Monday. I hope it is good news. -- PRESS RELEASE: Encysive Pharmaceuticals Announces Plans to Release Topline Data -- Encysive Pharmaceuticals Announces Plans to Release Topline Data From STRIDE-2 Clinical Trial HOUSTON, Feb. 11 /PRNewswire-FirstCall/ -- Encysive Pharmaceuticals (Nasdaq: ENCY) today announced plans to release topline data from STRIDE-2, the Company's Phase III pivotal clinical trial of Thelin(TM) (sitaxsentan) in patients with pulmonary arterial hypertension (PAH), on Monday morning, February 14, 2005. The Company will hold a live investor presentation in Manhattan to be made accessible via teleconference and webcast, beginning at 8:15 a.m. EST. Investors are invited to attend the presentation at the Four Seasons Hotel, 57 E. 57th Street New York, NY (Cosmopolitan Suite). To participate via teleconference, dial 1-800-901-5213; passcode 53735498. The presentation can also be monitored via the internet at encysive.com . A replay of the webcast will be available on the Company's website through Monday, March 14, 2005. A replay of the call can also be accessed until the same date by dialing 1-888-286-8010; passcode 76025230.

To: Biomaven who wrote (692)	6/18/2005 1:16:30 PM
From: Galirayo	Respond to of 3722

[AMLN] It needs just a little more Oooommph. Not much though. ttrader.com

To: Biomaven who wrote (692)	7/28/2005 3:42:24 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

APPX (On Peter's List.<g>) is going over its June & July Hs today.as it is trading above its June 1 H of 45.18 and it seems it may try to test its May 5 H at 48.62 The 1st Q results showed a 27% improvement on revenues to $124.5M and a 180% improvement on earnings to $0.28/shr vs, $0.10/shr in 2004.<g> The EE for 2005 are around $1.65 vs. $0.77/shr in 2004 and for 2006 the EE are around $2.15/shr. <g> APPX reportedly has around $0.65 in cash/shr and no significant LTD. It reportedly is also CF + $44.8M although still not FCF+ <g> The stock has closed its January 10 upgap and is up more than 6% today with volume now over 1,020,987 but still below the 3,347.702 of last Friday.<g> bigcharts.marketwatch.com Bernard